Cargando…
Molecular Characterization of a Fully Human Chimeric T-Cell Antigen Receptor for Tumor-Associated Antigen EpCAM
The transduction of T cells to express chimeric T-cell antigen receptor (CAR) is an attractive strategy for adaptive immunotherapy for cancer, because the CAR can redirect the recognition specificity of T cells to tumor-associated antigens (TAAs) on the surface of target cells, thereby avoiding the...
Autores principales: | Shirasu, Naoto, Yamada, Hiromi, Shibaguchi, Hirotomo, Kuroki, Motomu, Kuroki, Masahide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324174/ https://www.ncbi.nlm.nih.gov/pubmed/22547929 http://dx.doi.org/10.1155/2012/853879 |
Ejemplares similares
-
Corrigendum to “Molecular Characterization of a Fully Human Chimeric T-Cell Antigen Receptor for Tumor-Associated Antigen EpCAM”
por: Shirasu, Naoto, et al.
Publicado: (2015) -
Enhancement of antitumor activity by using a fully human gene encoding a single-chain fragmented antibody specific for carcinoembryonic antigen
por: Shibaguchi, Hirotomo, et al.
Publicado: (2017) -
Highly versatile cancer photoimmunotherapy using photosensitizer-conjugated avidin and biotin-conjugated targeting antibodies
por: Shirasu, Naoto, et al.
Publicado: (2019) -
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
Characterization of Carcinoembryonic Antigen‐related Antigens in Normal Adult Feces
por: Matsuoka, Yuji, et al.
Publicado: (1990)